Sign in
4

Changes in Ownership

Compass Therapeutics, Inc. Filed Acc 0001171843-25-000735

CEO gave up 41,687 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Schuetz Thomas J. CEO 2025-02-08 Shares withheld for taxes −41,687 $3.50 $145,905 6,470,825 D
Loading xslF345X05/ownership.xml…